Clinical Trial Update: Pregabalin Epilepsy Add-On Trial [Phase 3]

View source ↗

Summary

Phase 3 trial update for pregabalin as add-on therapy in partial seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Partial Seizures | Phase 3 | Status: COMPLETED